Relationship Graph Explorer
Follow the connections
Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.
🌿
Herb
6,826
→
⚗️
Ingredient
45,885
→
🧬
Gene Target
15,695
→
🏥
Disease
30,467
→
🧪
Evidence
23,241
trials · metas · refs
Plus 6,743 TCM formulas connecting herbs together
🏥 Disease / Health Topic
Carcinoma, Non-Small-Cell Lung
24
Clinical Trials
0
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT02655913
Safety and Efficacy of Vitamin C Infusion in Combination With Local mEHT to Treat Non Small Cell Lung Cancer
Completed · Phase 1|Phase 2
NCT03799094
Vitamin C and Tyrosine Kinase Inhibitor in Lung Cancer Patients With Epidermal Growth Factor Receptor Mutations
Unknown · Phase 1|Phase 2
NCT00001450
Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cisplatin for Patients With Stage III/IV and Relapsed NSCLC
Completed · Phase 2
📊 Sample Meta-Analyses
None linked yet.
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Carcinoma, Non-Small-Cell Lung
🏥 Names
Disease Name
Carcinoma, Non-Small-Cell Lung
Topic Type
disease
🔍 Raw view — every non-empty column on this row (14 fields)
name
Carcinoma, Non-Small-Cell Lung
topic type
disease
tcmsp disease id
135
📋 Clinical Trials
12 · subject of clinical studyNCT02655913 Safety and Efficacy of Vitamin C Infusion in Combination With Local mEHT to Trea
→ Carcinoma, Non-Small-Cell Lung|Stage IIIA Non-smal
NCT03799094 Vitamin C and Tyrosine Kinase Inhibitor in Lung Cancer Patients With Epidermal G
→ Carcinoma, Non-Small-Cell Lung
NCT00001450 Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cispla
→ Carcinoma, Non-Small-Cell Lung|Lung Neoplasms
NCT00001499 Phase II Neoadjuvant Trial of a Continuous Infusion of Paclitaxel Plus Cisplatin
→ Carcinoma, Non-Small-Cell Lung|Lung Neoplasms
NCT00035152 Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin R
→ Carcinoma, Non-Small-Cell Lung
NCT00049790 Safety and Efficacy Study of rhAngiostatin Administered in Combination With Pacl
→ Carcinoma, Non-Small-Cell Lung
NCT00071188 ZD6474 Alone or in Combination With Paclitaxel and Carboplatin in Subjects With
→ Carcinoma, Non-Small-Cell Lung
NCT00087802 Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell
→ Carcinoma, Non-Small-Cell Lung
NCT00088556 Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced N
→ Carcinoma, Non-Small-Cell Lung
NCT00147537 Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung
→ Carcinoma, Non-Small-Cell Lung
NCT00178256 Pulsed Paclitaxel And Daily Thoracic Radiotherapy For Inoperable (Stage I/II) Or
→ Carcinoma, Non-Small-Cell Lung
NCT00603538 Study of CP-751,871 in Combination With Carboplatin and Paclitaxel in Advanced L
→ Carcinoma, Non-Small-Cell Lung
How to read these connections
Each box lists records connected to the one you are viewing, and says how the connection was made. A connection shows that two records are related in the source data. It does not show that something works, is safe or should be used, and a record with many connections is not necessarily better studied or more effective.
- Study records (trials, systematic reviews, publications): the study names this subject. Registered or ongoing studies have no results here, and animal or cell research does not show an effect in people.
- Source-database links (for example herb and compound, compound and gene target): taken from the imported databases and not independently checked by us.
- Name matches (for example formula and herb, or a condition named in a study): found by matching names, so they can be wrong. Treat them as leads, not findings.